Featured
-
-
News |
Gut microbes linked to fatty diet drive tumour growth
Scientists know there is a link between obesity and some cancers. A study in mice and people suggests why that might be.
- Gillian Dohrn
-
News & Views |
Dual-action obesity drug rewires brain circuits for appetite
A two-in-one drug that modulates neural pathways involved in appetite and reward might prove to be more effective and longer lasting than current weight-loss drugs on the market.
- Tyler M. Cook
- & Darleen Sandoval
-
News |
Experimental obesity drug packs double punch to reduce weight
Test of weight-loss candidate in mice shows that there is still room for improvement in a burgeoning field.
- Asher Mullard
-
Article
| Open AccessGLP-1-directed NMDA receptor antagonism for obesity treatment
Unimolecular integration of NMDA receptor antagonism with GLP-1 receptor agonism effectively reverses obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease.
- Jonas Petersen
- , Mette Q. Ludwig
- & Christoffer Clemmensen
-
Correspondence |
Interpersonal therapy can be an effective tool against the devastating effects of loneliness
- Myrna M. Weissman
- & Jennifer J. Mootz
-
Outlook |
How ignorance and gender inequality thwart treatment of a widespread illness
Tens of millions of people have female genital schistosomiasis, a neglected tropical disease that few physicians have even heard of. Efforts are under way to move it out of obscurity and empower women and girls to access sexual and reproductive health care.
- Claire Ainsworth
-
News |
Bird flu in US cows: where will it end?
Scientists worry that the H5N1 strain of avian influenza will become endemic in cattle, which would aid its spread in people.
- Sara Reardon
-
Article
| Open AccessDiscovery of potent small-molecule inhibitors of lipoprotein(a) formation
Biochemical screening and optimization identify small molecules that inhibit the formation of lipoprotein(a), and these inhibitors reduce the levels of Lp(a) in several animal models, suggesting that they could provide a therapeutic option in humans.
- Nuria Diaz
- , Carlos Perez
- & Laura F. Michael
-
Article |
A meta-analysis on global change drivers and the risk of infectious disease
Reducing greenhouse gas emissions, managing ecosystem health, and preventing biological invasions and biodiversity loss could help to reduce the burden of plant, animal and human diseases, especially when coupled with improvements to social and economic determinants of health.
- Michael B. Mahon
- , Alexandra Sack
- & Jason R. Rohr
-
Nature Podcast |
Sex and gender discussions don't need to be toxic
The science of sex and gender is too often misinterpreted and weaponized. Now, three experts cut through the misinformation in search of a positive future for this long-neglected area of research
- Lucy Odling-Smee
- , Florence Ashley
- & Noah Baker
-
Comment |
Male–female comparisons are powerful in biomedical research — don’t abandon them
Binary sex studies have been denounced as too simplistic, but dropping them altogether would impede progress in a long-neglected area of biomedicine.
- Arthur P. Arnold
- , Sabra L. Klein
- & Jeffrey S. Mogil
-
News & Views |
Cells destroy donated mitochondria to build blood vessels
Organelles called mitochondria are transferred to blood-vessel-forming cells by support cells. Unexpectedly, these mitochondria are degraded, kick-starting the production of new ones and boosting vessel formation.
- Chantell S. Evans
-
Article
| Open AccessMultimodal decoding of human liver regeneration
Harnessing single-nucleus RNA sequencing and spatial profiling, this work dissects unanticipated aspects of human liver regeneration to uncover a novel migratory hepatocyte subpopulation mediating wound closure following acute liver injury.
- K. P. Matchett
- , J. R. Wilson-Kanamori
- & N. C. Henderson
-
Nature Podcast |
Audio long read: Why loneliness is bad for your health
New research is revealing the mechanisms linking loneliness and conditions like dementia, depression and cardiovascular disease.
- Saima May Sidik
- & Benjamin Thompson
-
News & Views |
Targeting RNA opens therapeutic avenues for Timothy syndrome
A therapeutic strategy that alters gene expression in a rare and severe neurodevelopmental condition has been tested in stem-cell-based models of the disease, and has been shown to correct genetic and cellular defects.
- Silvia Velasco
-
Article |
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
VVD-133214, a clinical-stage, covalent allosteric inhibitor of the helicase WRN, was well tolerated in mice and led to robust tumour regression in multiple microsatellite-instability-high colorectal cancer cell lines and patient-derived xenograft models.
- Kristen A. Baltgalvis
- , Kelsey N. Lamb
- & Todd M. Kinsella
-
Editorial |
Any plan to make smoking obsolete is the right step
The United Kingdom is correct to attempt to end the single largest preventable cause of illness and death, as was New Zealand before its government changed its mind.
-
Spotlight |
Deadly diseases and inflatable suits: how I found my niche in virology research
Virologist Hulda Jónsdóttir studies some of the world’s most pathogenic viruses at the Spiez Laboratory in Switzerland.
- Nikki Forrester
-
News Feature |
Obesity drugs aren’t always forever. What happens when you quit?
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.
- McKenzie Prillaman
-
News Feature |
The rise of eco-anxiety: scientists wake up to the mental-health toll of climate change
Researchers want to unpick how climate change affects mental health around the world — from lives that are disrupted by catastrophic weather to people who are anxious about the future.
- Helen Pearson
-
Research Briefing |
Genetic risk variants lead to type 2 diabetes development through different pathways
The largest genome-wide association study for type 2 diabetes so far, which included several ancestry groups, led to the identification of eight clusters of genetic risk variants. The clusters capture different biological pathways that contribute to the disease, and some clusters are associated with vascular complications.
-
Nature Podcast |
The ‘ghost roads’ driving tropical deforestation
Researchers find that a huge number of roads that don’t appear on official maps, and the protein that could determine whether someone is left-handed.
- Nick Petrić Howe
- & Benjamin Thompson
-
Article |
Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids
Glucocorticoids reprogram the mitochondrial metabolism of macrophages, resulting in increased and sustained production of the anti-inflammatory metabolite itaconate and, as a consequence, inhibition of the inflammatory response.
- Jean-Philippe Auger
- , Max Zimmermann
- & Gerhard Krönke
-
Correspondence |
Use fines from EU social-media act to fund research on adolescent mental health
- Christian Montag
- & Benjamin Becker
-
Technology Feature |
‘Without these tools, I’d be lost’: how generative AI aids in accessibility
A rush to place barriers around the use of artificial intelligence in academia could disproportionately affect those who stand to benefit most.
- Amanda Heidt
-
News |
Diabetes drug slows development of Parkinson’s disease
The drug, which is in the same family as blockbuster weight-loss drugs such as Wegovy, slowed development of symptoms by a small but statistically significant amount.
- David Adam
-
News Feature |
Why loneliness is bad for your health
A lack of social interaction is linked to a higher risk of cardiovascular disease, dementia and more. Researchers are unpicking how the brain mediates these effects.
- Saima May Sidik
-
Article |
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
Interim data from a clinical trial of mRNA-3927—an mRNA therapeutic for propionic acidaemia—provide early indications of the safety and efficacy of the treatment, and suggest that this approach might be applicable to other rare diseases.
- Dwight Koeberl
- , Andreas Schulze
- & Stephanie Grunewald
-
Article
| Open AccessAncestral allele of DNA polymerase gamma modifies antiviral tolerance
The POLG1 mutation p.W748S, which is associated with mitochondrial recessive ataxia syndrome, dampens innate immune responses by compromising mtDNA replisome stability, and this explains why a viral infection can trigger the development of the disease and contribute to its variable clinical manifestation.
- Yilin Kang
- , Jussi Hepojoki
- & Anu Suomalainen
-
News |
‘Mini liver’ will grow in person’s own lymph node in bold new trial
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time.
- Max Kozlov
-
Research Highlight |
Green space near home has an antidepressant effect
People who had the most vegetation near their residences were the least likely to report depression and anxiety.
-
Book Review |
The great rewiring: is social media really behind an epidemic of teenage mental illness?
The evidence is equivocal on whether screen time is to blame for rising levels of teen depression and anxiety — and rising hysteria could distract us from tackling the real causes.
- Candice L. Odgers
-
Outlook |
The future of at-home molecular testing
The COVID-19 pandemic showed what was possible for gene-based diagnostics. Now comes the true test – economics.
- Elie Dolgin
-
News |
Google AI could soon use a person’s cough to diagnose disease
Machine-learning system trained on millions of human audio clips shows promise for detecting COVID-19 and tuberculosis.
- Mariana Lenharo
-
News |
Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost
The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.
- Smriti Mallapaty
-
Nature Podcast |
AI hears hidden X factor in zebra finch love songs
Machine learning detects song differences too subtle for humans to hear, and physicists harness the computing power of the strange skyrmion.
- Nick Petrić Howe
- & Benjamin Thompson
-
News Explainer |
Ketamine is in the spotlight thanks to Elon Musk — but is it the right treatment for depression?
The entrepreneur endorses the drug, but researchers caution that it’s not to be taken lightly.
- David Adam
-
Article
| Open AccessTranscription–replication conflicts underlie sensitivity to PARP inhibitors
Poly(ADP-ribose) polymerase 1 (PARP1) functions together with TIMELESS and TIPIN to protect the replisome in early S phase from transcription–replication conflicts, and inhibiting PARP1 enzymatic activity may suffice for treatment efficacy in homologous recombination-deficient settings.
- Michalis Petropoulos
- , Angeliki Karamichali
- & Thanos D. Halazonetis
-
-
News |
Bird-flu threat disrupts Antarctic penguin studies
Projects have been cancelled in an effort to curb the virus’s spread.
- Carissa Wong
-
News |
First US drug approved for a liver disease surging around the world
A therapy called resmetirom improves hallmarks of an obesity-linked condition that can lead to liver failure.
- Heidi Ledford
-
Outlook |
Fungal diseases are spreading undetected
Low- and middle-income countries are grappling with widespread shortages of diagnostic tests for infections that kill millions.
- Charles Schmidt
-
Nature Index |
Researchers call for a major rethink of how Alzheimer’s treatments are evaluated
An approach that aims to quantify how long a drug can delay or halt the progression of disease is gathering steam.
- Esther Landhuis
-
News |
Ancient malaria genome from Roman skeleton hints at disease’s history
Genetic information from ancient remains is helping to reveal how malaria has moved and evolved alongside people.
- Tosin Thompson
-
Research Briefing |
Dysregulated cellular stress management becomes a source of stress
Stress responses protect cells from harmful conditions, but once the stress has resolved, these responses must be actively turned off to avoid cell damage that might lead to the development of neurodegenerative disease.
-
News |
Blockbuster obesity drug leads to better health in people with HIV
Semaglutide reduces weight and fat accumulation associated with the antiretroviral regimen that keeps HIV at bay.
- Mariana Lenharo
-
News Explainer |
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
Therapy built on tumour-infiltrating lymphocytes is now being prepared for at least 20 people in the United States with advanced melanoma.
- Sara Reardon
-
Outlook |
Could the gut give rise to alcohol addiction?
Microorganisms in the gut might make a person more vulnerable to substance-use disorders.
- Tammy Worth
-
Nature Podcast |
These tiny fish combine electric pulses to probe the environment
Elephantnose fish share electric pulses to extend their senses, and the bumblebees that show a uniquely human trait.
- Nick Petrić Howe
- & Benjamin Thompson
Browse broader subjects
Browse narrower subjects
- Cancer
- Cardiovascular diseases
- Dental diseases
- Endocrine system and metabolic diseases
- Eye diseases
- Gastrointestinal diseases
- Haematological diseases
- Immunological disorders
- Infectious diseases
- Kidney diseases
- Metabolic disorders
- Neurological disorders
- Nutrition disorders
- Oral diseases
- Psychiatric disorders
- Reproductive disorders
- Respiratory tract diseases
- Rheumatic diseases
- Skin diseases
- Trauma
- Urogenital diseases